Connect with us
ATB Therapeutics secured €54 million in Series A funding, one of Belgium's largest early-stage biotech raises. Backed by major global investors like EQT Life Sciences and...
Sanofi's €40M capital boost will scale Thymoglobulin production for kidney transplant rejection and internalize diabetes drug Tzield development, acquired via Provention Bio. The investment enhances reliability,...
Better Care and Oracle's partnership aims to revolutionize health data management, enhancing secure cloud storage and data flow efficiency. This collaboration supports faster diagnostics and treatments...
Brookfield agreed with Santander and Deutsche Bank to raise €11 billion for Grifols' debt refinancing, potentially Spain's largest syndicated loan. This funding is vital for Brookfield’s...
At an IDIS Foundation meeting, Abbott introduced two minimally invasive devices, MitraClip and TriClip, aimed at treating mitral and tricuspid regurgitation without open-heart surgery. Presented by...
Laminar Pharma raised €5.9 million, led by the Matutes family, for its growth and launch of anti-tumor drug LAM 561, aimed at glioblastoma treatment. Additional investors...
Bayer reported €4.18 billion in third-quarter losses, mainly due to agricultural division asset impairment. Revenues fell 3.6% to €9.97 billion, with agriculture down 8.7% and pharmaceuticals...
Moderna’s revenue fell 43.7% year-over-year to $2.27 billion between January and September, though losses decreased from $4.93 billion to $2.44 billion. Third-quarter performance improved with $13...
Rovi's EBITDA fell by 2% to €167.2 million, and operating income decreased 5% to €564.6 million from January to September 2024, largely due to reduced COVID...
Leitat has strengthened its biotechnology focus by acquiring ReadyCell via MedTech Barcelona. This acquisition boosts Leitat's role in developing advanced cell kits for in vitro testing,...
 |
|
 |  |
 |
|